⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer

Official Title: An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer

Study ID: NCT05454488

Conditions

Prostate Cancer

Study Description

Brief Summary: To learn if using cryotherapy to treat only the part of the prostate known to contain cancer is effective in controlling prostate cancer

Detailed Description: Primary Objective: • To determine the effectiveness of an evidence-based focal cryotherapy ablation by measuring negative in-field recurrence rate at 6-months post-ablation. Secondary Objectives: * To determine quality of life following focal prostate cancer ablation using validated questionnaires (EPIC-26, AUA symptoms score, SHIM). * To establish PSA kinetics post-evidence-based focal cryotherapy ablation. * To determine rates of out of field recurrence on 6-month biopsy following focal cryotherapy ablation. * To determine MRI findings post-focal cryotherapy ablation, including those related to prostate and surrounding periprostatic fat volume. * To determine rate of progression and re-intervention collected as part of standard of care treatment for 5-year following study treatment. * To describe financial toxicity associated with focal prostate cancer treatment using cryotherapy. * To describe the incidence and severity of complications within 30-days after the study focal ablation treatment. * To describe imaging findings on PSMA PET MRI performed in a subset of men after standard of care focal cryotherapy prior to 6-month biopsy.

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: MALE

Healthy Volunteers: No

Locations

MD Anderson Cancer Center, Houston, Texas, United States

Contact Details

Name: Justin Gregg, MD

Affiliation: jrgregg@mdanderson.org

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: